Title	Publication Date	Language	Citations
Poster Abstract #13: Interactive Voice Response Diary and Objective Myotonia Measurement as Endpoints for Clinical Trials in Nondystrophic Interactive Voice Response Diary and Objective Myotonia Measurement as Endpoints for Clinical Trials in Nondystrophic Myotonia	2008/07/01	English
Contents	2008/07/01	English
Poster Abstract #10: Prevalence of Adverse Non-drug-related Symptoms in Volunteers to Phase I Studies and in Normal Population	2008/07/01	English
Poster Abstract #5: NIH Roadmap Molecular Libraries Screening Centers Network	2008/07/01	English
Poster Abstract #12: Brain and Plasma Pharmacokinetics of Three Dopamine Transporter (DAT)-Selective Blockers After Administration of a Range of Single Oral Doses in Conscious Mice	2008/07/01	English
Poster Abstract #6: Absorption, Distribution, Metabolism, and Excretion of 14C-labeled Nebicapone (BIA 3-202) and Metabolites	2008/07/01	English
Poster Abstract #2: Surrogate Completion of the Treatment Satisfaction Questionnaire for Medication for a Trial of Corticosteroids in Duchenne Muscular Dystrophy	2008/07/01	English
Poster Abstract #7: Pharmacokinetic-Pharmacodynamic Interaction Between Nebicapone (BIA 3-202) and Controlled-release Levodopa/Benserazide (Madopar HBS 125)	2008/07/01	English
Editorial Board	2008/07/01	English
Poster Abstract #8: Effect of Nebicapone (BIA 3-202) on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects	2008/07/01	English
Poster Abstract #1: Clinically Meaningful Differences of the Ashworth Scale in Post-Stroke Upper Limb Spasticity	2008/07/01	English
Poster Abstract #9: Influence of the Personality Trait Anxiety on Adverse Non-Drug-Related Symptoms	2008/07/01	English
Poster Abstract #15: MRI Measurement of Whole Spinal Cord Volume at 3T: Reproducibility and Relevance to Multiple Sclerosis	2008/07/01	English
Poster Abstract #14: Magnetic Resonance Disease Severity Scale (MRDSS) Predicts Clinical Progression in Multiple Sclerosis	2008/07/01	English
Poster Abstract #11: Brain Microdialysate and Plasma Concentrations of Inosine During Intravenous Inosine Infusion in Conscious Rats	2008/07/01	English
Poster Abstract #4: Development of Long-Duration Accelerometry for Use in Clinical Trials of Essential Tremor	2008/07/01	English
Poster Abstract #3: mGluR5 Activation Reduces Microglial-Mediated Neurotoxicity in Vitro and Improves Outcome After Experimental Traumatic Brain Injury	2008/07/01	English
Commentary: Hormones, Diet, and Botanicals	2009/04/01	English
Long-Term Effects of Olanzapine on Motor Features and Weight in Huntington’s Disease	2008/04/01	English
First Report of Huntington’s Disease in West Asian Immigrants Living in the United States	2008/04/01	English
Editorial Board	2008/04/01	English
Sensitivity of the UHDRS Cognitive Tests in Pre-Diagnosis and Early Huntington’s Disease (HD)	2008/04/01	English
A Scale To Measure Quality of Life in Huntington’s Disease Spousal Carers	2008/04/01	English
Longitudinal Decline in Negative Emotion Recognition Prior to Diagnosis in Huntington’s Disease	2008/04/01	English
A Review of the Use of Concomitant Medication for Huntington’s Disease in Europe Between 2004 and 2007 Based on the European HD REGISTRY	2008/04/01	English
A Study in Pre-Manifest Huntington’s Disease of Coenzyme Q10 (Ubiquinone)	2008/04/01	English
Brain Correlates of Neuropsychological Function in Presymptomatic HD Gene Carriers	2008/04/01	English
Influence of Insurance on the Decision to Pursue Genetic Testing in Individuals at Risk for Huntington’s Disease	2008/04/01	English
Late-Onset Huntington’s Disease: A Review of 41 Cases	2008/04/01	English
Emerging Clinical Candidates From the CHDI Pipeline	2008/04/01	English